Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
An. bras. dermatol
; 94(4): 483-484, July-Aug. 2019. tab
Article
in English
| LILACS
| ID: biblio-1038303
Responsible library:
BR1.1
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Arthritis, Psoriatic
/
Antirheumatic Agents
/
Biosimilar Pharmaceuticals
/
Infliximab
/
Antibodies, Monoclonal
Type of study:
Evaluation study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Aged, 80 and over
/
Female
/
Humans
/
Male
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2019
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Regional da Asa Norte/BR
/
Universidade de Brasília/BR